Product Information

ENALAPRIL MALEATE 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0757 per EA under NDC 64980068601. Its NADAC has been published 52 times since Aug 27, 2025.

FDA first approved this application on Sep 19, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENALAPRIL MALEATE 5 MG TABLET

ENALAPRIL MALEATE
$0.0757per EA

Strength

5 mg/1

NDC

64980068601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ENALAPRIL MALEATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218531

FDA Approved

9/19/2024

TE Code

AB

On Market Since

2/24/2025

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Decreased Blood Pressure

Price Statistics

The NADAC for ENALAPRIL MALEATE 5 MG TABLET has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0757 per EA
All-time high$0.0819 (Oct 15, 2025)
All-time low$0.0709 (Mar 18, 2026)
52-week high$0.0819
52-week low$0.0709
Median price$0.0746
Average price$0.0753
Largest weekly change-10.1% (Jul 22, 2026)
Weeks tracked52
Tracking sinceAug 27, 2025

Price History

1W

+6.5%

1M

+6.5%

3M

+2.9%

6M

+3.2%

1Y

N/A

3Y

N/A

5Y

N/A

All

-5.4%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of ENALAPRIL MALEATE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENALAPRIL MALEATE 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0757 per EA (NDC 64980068601), effective Aug 19, 2026.

How has the price of ENALAPRIL MALEATE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENALAPRIL MALEATE 5 MG TABLET has declined 5.4%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for ENALAPRIL MALEATE 5 MG TABLET?

Since Aug 27, 2025, the NADAC for ENALAPRIL MALEATE 5 MG TABLET has ranged from a low of $0.0709 (Mar 18, 2026) to a high of $0.0819 (Oct 15, 2025), with a median of $0.0746 per EA.

Are there cheaper alternatives to ENALAPRIL MALEATE 5 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ENALAPRIL MALEATE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures ENALAPRIL MALEATE 5 MG TABLET?

ENALAPRIL MALEATE 5 MG TABLET (NDC 64980068601) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.